Mike Ouimette insider trades: Pliant Therapeutics (PLRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mike reports to the SEC
Open-market buys and sales
9 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | PLRX | ↓ Sell10b5-1 | 23,500 | $11.11 | $261K | Direct | Jan 22, 2025 (0d) |
| Jul 10, 2024 | PLRX | ↓ Sell10b5-1 | 7,656 | $11.56 | $89K | Direct | Jul 12, 2024 (2d) |
| Jan 17, 2024 | PLRX | ↓ Sell10b5-1 | 5,197 | $17.23 | $90K | Direct | Jan 19, 2024 (2d) |
| Jul 20, 2023 | PLRX | ↓ Sell | 4,755 | $17.55 | $83K | Direct | Jul 21, 2023 (1d) |
| Jul 17, 2023 | PLRX | ↓ Sell10b5-1 | 12,778 | $18.01 | $230K | Direct | Jul 19, 2023 (2d) |
| Apr 3, 2023 | PLRX | ↓ Sell10b5-1 | 7,751 | $26.62 | $206K | Direct | Apr 3, 2023 (0d) |
| Jan 23, 2023 | PLRX | ↓ Sell | 20,000 | $34.19 | $684K | Direct | Jan 25, 2023 (2d) |
| Dec 22, 2022 | PLRX | ↓ Sell | 2,928 | $19.38 | $57K | Direct | Dec 23, 2022 (1d) |
| Dec 20, 2022 | PLRX | ↓ Sell | 4,719 | $19.10 | $90K | Direct | Dec 21, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PLRX insiders
Open-market trades in the last 12 months
About Mike Ouimette's insider trades
Mike Ouimette is General Counsel & Corp. Sec'y at Pliant Therapeutics (PLRX). Since Dec 20, 2022, Mike has reported no open-market purchases and 9 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
5 sales (49% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (10 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.